RNABL
Live / Applied — Second extension granted (statement of use) (as of 11 Jul 2025)
What this means for you
Not registered yet, but its 08 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97113279
- Mark type
- Stylized text
- Filed
- 08 Nov 2021
- Published for opposition
- 21 May 2024
- Attorney of record
- Marina A. Sigareva
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the delivery of nucleic acid into a cell using an amine-containing compound for the prevention or treatment of disease and vaccines
Owner
- Tiba Biotech LLC, Cambridge, MA, US
- Tiba Biotech LLC, Cambridge, MA, US
Prosecution history
- 15 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 12 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2025 — SOU EXTENSION 2 GRANTED
- 11 Jul 2025 — SOU EXTENSION 2 FILED
- 11 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2025 — SOU EXTENSION 1 GRANTED
- 08 Jan 2025 — SOU EXTENSION 1 FILED
- 08 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION
- 01 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED